Doxorubicin Loaded Liposomal Nanoparticles Containing Quantum Dot for Treatment of Breast Cancer

Document Type : Research Article

Authors

1 Department of Chemical Engineering, Tehran Science and Research Branch, Islamic Azad University, Tehran, I.R. IRAN

2 Department of Nanobiotechnology, Pasteur Institute of Iran, Tehran, I.R. IRAN

3 Department of Chemical Engineering, South Tehran Branch, Islamic Azad University, Tehran, I.R. IRAN

Abstract

In addition to increasing the efficacy of various drugs, Nanoparticles reduce their side effects. In this study, different nanoparticle formulations of Doxorubicin anticancer drugs were prepared. The efficacy of the formulations produced in the cell culture medium was studied compared with the free drug. Reverse phase evaporation was used to form the liposome containing doxorubicin. The graphite nanoparticles were prepared. These nanoparticles were mixed with the liposome containing doxorubicin, and the related Nano-complex was conjugated. Spectroscopy methods for visible light-ultraviolet, light and light dynamics differentiation were used to describe nanoparticles. For the toxicity of different formulation, MTT and MCF-7 cells were used. The amount of drug loading in the liposomes was 72%. The largest amount was related to the Nano-conjugated complex and the smallest size was related to the graphene-oxide nanoparticle with a nanometer size. The controlled release in 96 hours and the amount of drug release was 95.43%. Doxorubicin-containing liposome toxicity was 75% and Nano- conjugated complex was 85%, at the lowest drug concentration (10µM). The free drug created 35% cell toxicity in 10µM and 89% in 2500µM. The results of the study showed Liposomes act as a suitable nanoparticle for doxorubicin. It was found that the effect of nanoparticles of graphene oxide is very important. In the presence of this nanoparticle in the complex, toxicity increased significantly.

Keywords

Main Subjects

References

[1] Alavi S.E., Koohi Moftakhari Esfahani M., Alavi F., Movahedi F., Akbarzadeh A., Drug Delivery of Hydroxyurea to Breast Cancer Using Liposomes, Ind J Clin Biochem, 19(2): 12-29 (2012).
[2] Al-Jamal W.T., Kostarelos K., Liposome-Nanoparticle Hybrids for Multimodal Diagnostic and Ther-Apeutic Application, Nanomedicine, 2(1): 85-98 (2007).
[3] Behroozeh A., Mazloumi Tabrizi M., Kazemi S.M., Choupani E., Kabiri N., Ilbeigi D., Heydari Nasab A., Akbarzadeh Khiyavi A., Seif Kurdi A., Evaluation the Anti-Cancer Effect of PEGylated Nano-Niosomal Gingerol, on Breast Cancer Cell lines (T47D), In-Vitro. APJCP, 19(3):645-648 (2018).
[4] Burda C., Chen X., Narayanan R., El-Sayed M.A., Chemistry and Properties of Nanocrystals of Different Shapes, Chem Rev, 105(4):1025–102 (2005).
[5] Coradeghini R., Gioria S., García C.P., Nativo P., Franchini F., Gilliland D., Ponti J., Rossi F., Size-de-Pendent Toxicity and Cell Interaction Mechanisms of Gold Nanoparticles on Mouse Fibroblasts, Toxicol Lett, 217(3): 205-16 (2013).
[6] Costantino L., Boraschi D., Is there a Clinical Future for Polymeric Nanoparticles as Brain-Target-Ing Drug Delivery Agents? Drug Discov Today, 17(7-8): 367-78 (2012).[7] Daniel M.C., Astruc D., Gold Nanoparticles: Assembly, Supramolecular Chemistry, Quantum-Size-re-Lated Properties, and Applications Toward Biology, Catalysis, and Nanotechnology, Chem Rev, 9(3):39-52(2012)
[8] Devika B., Chithrani, Michael Dunne, BASc, James Stewart, MASc, Christine Allen, David A.  Jaffray. Cellular Uptake and transport of Gold Nanoparticles Incorporated in a Liposomal Carrier. Nanomedicine: Nanotechnology, Biology, and Medicine, 6(1): 161–169 (2017).
[9] Farahnak Zarabi M., Farhangi A., Khademi Mazdeh S., Ansarian Z., Zare D., Mehrabi M.R., Akbarzadeh A., Synthesis of Gold Nanoparticles Coated with Aspartic Acid and Their Conjugation with FVIII Protein and FVIII Antibody, Ind J Clin Bio-chem. 2013; doi: 10.1007/s12291-013-0323-2.
[10] Haghiralsadat F., Amoabediny G., Helder M.N., Naderinezhad S., Sheikhha M.H., Forouzanfar T., Zandieh-Doulabi B., A Comprehensive Mathematical Model of Drug Release Kinetics from Liposome, Derived from Optimization Studies of Cationic Pegylated Liposomal Doxorubicin Formulations for Drug-Gene Delivert, Artif Cells Nanomed Biotechnol, 17(25):11-21 (2017).
[11] Heidary Alizadeh B., Vosooghi M., Khoobi M., Javidnia A.,; Foroumadi A., Panah F., Safavi M., Ardestani S., Shafiee A., Synthesis and Cytotoxic Activity of Novel 9-[Hydroxy(Substitutedphenyl) Methyl]-2,2- Dimethyl-2,3,8,9-Tetrahydro-4H,10H-Pyrano [2,3-f] Chromene-4,10-Diones, Iranian Journal of Chemistry and Chemical Engineering (IJCCE), 29(4): 189-196 (2010). 
[12] Hong K., Friend D.S., Glabe C.G., Papahadjopoulos D., Liposomes Containing Colloidal Gold are a Useful Probe of Liposome-Cell Interactions, Biochim Biophys Acta, 732 (1):320–323 (1983).
[13] Immordino M.L., Dosio F., Cattel L., Stealth Liposomes: Review of the Basic Science, Rationale, and Clinical Applications, Existing and Potential, Int J Nanomed, 1(3): 297–315 (2016).
[14] Jung T., Kamm W., Breitenbach A., Kaiserling E., Xiao J.X., Kissel T., Biodegradable Nanoparticles for Oral Delivery of Peptides: is There a Role for Polymers to Affect Mucosal Uptake?, Eur. J. Pharm. Biopharm,  50: 147-60 (2012).
[15] Kanaani L., Mazloumi Tabrizi M., Akbarzadeh A., Javadi I., Improvement the Efficacy of Cisplatin by Niosome Nanoparticles against Human Breast Cancer Cell Line BT-20: An in Vitro Study, APJCB, 2(2): 25-26 (2017).
[16] Kojima C., Hirano Y., Kono K., Chapter 7 - Preparation of Complexes of Liposomes with Gold Nanoparticles, Methods Enzymol, 464: 131-145 (2009).
[17] Liebelt E.L., Balk S.J., Faber W., Fisher J.W., Hughes C.L., Lanzkron S.M., Lewis K.M., Marchetti F., Mehendale H.M., Rogers J.M., Shad A.T., Skalko R.G., Stanek E.J., NTP-CERHR Expert Panel Report on the Reproductive and Developmental Toxicity of Hydroxyurea., 80(4): 259-366 (2007).
[18] Liu X., Huang G., Formation Strategies, Mechanism of Intracellular Delivery and Potential Clinical Aplications of pH Sensitive Liposomes, Asian Journal of Pharmaceutical Sciences,28(4):288-95 (2013).
[19] Mahmoud Mady M., Mahmoud Fathy M., Youssef T., Mohamed Khalil W., Biophysical Characterization of Gold Nanoparticles-Loaded Liposomes, Physica Medica, 28(4): 288-295 (2012).
[20] Mazloomi Tabrizi M., Arbabi Bidgoli S., Increased Risk of Childhood Acute Lymphoblastic Leukemia (ALL) by Prenatal and Postnatal Exposure to High VoltagePower Lines : A Case Control Study in Isfahan, Iran. APJCP, 16(6): 2347-2350 (2015).
[21] Mazloumi Tabrizi M., Hosseini S.A., Role of Electromagnetic Field Exposure in Childhood Acute Lymphoblastic Leukemia and No Impact of Urinary Alpha-Amylase--a Case Control Study in Tehran, Iran,  APJCP, 16(17):7613-7618 (2015).
[22] Mozafari M.R., Nanocarrier Technologies, Frontiers of Nanotherapy, 237(5): 1-12 (2006).
[23] Nimesh S., Manchanda R., Kumar R., Saxena A., Chaudhary P., Yadav V., Mozumdar S., Chandra R., Preparation, Characterization and in Vitro Drug Release Studies of Novel Polymeric Nanoparticles,  Int. J. Pharm., 323(1-2): 146-152 (2006).
[24] Paasonen L., Laaksonen T., Johans C., Yliperttula M., Konttun K., Urtti A., Gold Nanoparticles Enable Selective Light-Induced Contents Release from Liposomes, J. Control Release, 122(1): 86–93 (2007).
[25] Paolino D., Fresta M., Sinha P., Ferrari M., “Drug Delivery Systems”, In: Webester J.G., (Editor). “Encyclo-Pedia of Medical Devices and Instrumentation”, 2nd ed. John Wiley and Sons, Inc., 437-495 (2006).
[26] Park S.H., Oh S.G., Mun J.Y., Han S.S., Loading of Gold Nanoparticles Inside the DPPC Bilayers of Liposome and Their Effects on Membrane Fluidities, Colloids Surf B Biointerfaces, 15;48(2): 112-118 (2006).
[27] Soppimath K., Aminabhavi T.M., Kulkarni A.R., Rudzinski W.E., Biodegradable Polymeric Nanopar-Ticles as Drug Delivery Devices, J. Controlled Release, 70 (1-2): 1-20 (2001).
[28] Vinogradov S.V., Bronich T.K., Kabanov A.V., Nanosized Cationic Hydrogels for Drug Delivery: Prepa-Ration, Properties and Interactions with Cells, Adv. Drug. Deliv. Rev., 54(1): 135-147 (2002).
[29] Volodkin D.V., Skirtach A.G., Mohwald H., Near-IR Remote Release from Assemblies of Liposomes and Nanoparticles, Angew. Chem. Int. Ed. Engl., 48(10): 1807–1809 (2009).
[30] Wang X., Yang L., Chen Z.(Georgia), Dong M. Shin., Application of Nanotechnology in Cancer Therapy and Imaging, CA Cancer J. Clin., 58(2): 97-110 (2008).
[31] William M., Strauss. Preparation of Genomic DNA from Mammalian Tissue, Current Protocols in Molecular Biology,48(7) 221-223 (1998).
[32] Wu G., Mikhailovsky A., Khant H.A., Fu C., Chiu W., Zasadzinski J.A., Remotely Triggered Liposome Release by Near-Infrared Light Absorption via Hollow Gold Nanoshells, J. Am. Chem. Soc.,118(2) 130- 139   (2008).
Iranian Journal of Chemistry and Chemical Engineering
Volume 38, Issue 5 - Serial Number 97
September and October 2019
Pages 45-53

Files

Share

How to cite

Statistics